Wall Street Zen upgraded shares of Nutex Health (NASDAQ:NUTX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday,Wall Street Zen reports.
Several other equities analysts have also weighed in on the stock. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. Lake Street Capital reaffirmed a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health currently has a consensus rating of “Buy” and an average target price of $317.50.
Read Our Latest Report on Nutex Health
Nutex Health Stock Up 2.0%
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. As a group, equities analysts anticipate that Nutex Health will post 27.58 earnings per share for the current year.
Insider Buying and Selling
In other Nutex Health news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the transaction, the director owned 400 shares of the company’s stock, valued at $85,700. This represents a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 44.68% of the stock is owned by insiders.
Institutional Investors Weigh In On Nutex Health
Institutional investors have recently made changes to their positions in the stock. WINTON GROUP Ltd purchased a new stake in shares of Nutex Health in the 2nd quarter valued at approximately $237,000. Allworth Financial LP boosted its position in shares of Nutex Health by 41.0% during the 2nd quarter. Allworth Financial LP now owns 203 shares of the company’s stock worth $35,000 after purchasing an additional 59 shares during the period. Arizona State Retirement System acquired a new stake in Nutex Health in the 2nd quarter valued at approximately $230,000. Corient Private Wealth LP increased its holdings in Nutex Health by 5.1% in the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock valued at $1,142,000 after purchasing an additional 325 shares during the last quarter. Finally, Amundi acquired a new stake in Nutex Health in the 2nd quarter valued at approximately $378,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.
About Nutex Health
Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.
The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.
See Also
- Five stocks we like better than Nutex Health
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
